New Cell Type Discovered in Prostate Cancer Linked to Nerve Growth & Spread

A newly detailed map of prostate cancer cells, including the surprising discovery of a previously unknown cell type, is offering researchers fresh insights into how the disease develops and spreads. The perform, led by researchers at the Institute of Cancer Research, London, and published recently, isn’t immediately changing clinical practice, but it’s laying the groundwork for more precise early detection and treatment strategies for a cancer that affects thousands of men each year.

Unveiling Perineural Cancer-Associated Fibroblasts

Central to this advance is the identification of what researchers are calling perineural cancer-associated fibroblasts – connective tissue cells found near nerves within tumors. These cells appear to have specialized mechanisms for communicating with nerves, a connection that has long been suspected to play a role in the progression of prostate cancer. “These perineural fibroblasts in tumours appear to have specialised machinery to communicate with nerves,” explains Professor Paul Swarbrick, lead author of the study. “We don’t yet understand what these cells are doing, but the role of nerves in tumours is getting increasing attention in the cancer field. We’ve been able to classify these cells at the molecular level for the first time, giving them a distinct identity.”

The tendency for prostate tumors to grow in and around nerves has been consistently linked to poorer patient outcomes. This discovery of specialized cells that interact with these nerves provides a crucial new piece of the puzzle, helping scientists understand how prostate tumors might recruit nerves or utilize them as pathways for metastasis – the spread of cancer to other parts of the body. The research team used a combination of techniques, including genomic sequencing and spatial transcriptomics, to create a detailed “cell atlas” of prostate cancer, essentially a comprehensive catalog of the different cell types present within the tumor microenvironment. Similar work has highlighted the importance of nerve-fibroblast interactions in other cancers, like pancreatic cancer, where sympathetic nerves influence tumor growth.

Why Nerves Matter in Cancer Progression

The connection between cancer and the nervous system is increasingly recognized as a critical area of study. Nerves aren’t simply passive bystanders within a tumor; they can actively contribute to cancer progression in several ways. They can release growth factors that stimulate cancer cell proliferation, provide a physical pathway for cancer cells to spread, and even influence the immune response within the tumor microenvironment. Recent research has shown that nociceptor neurons (involved in pain signaling) can interact with cancer-associated fibroblasts, impacting the immune system and promoting tumor growth in pancreatic cancer.

In prostate cancer, perineural invasion – the spread of cancer cells along nerves – is a common occurrence and a significant predictor of recurrence and metastasis. Understanding how these interactions are orchestrated at the cellular level is essential for developing strategies to disrupt them.

Expanding the Scope of the Cell Atlas

The research team acknowledges that this is just the beginning. Their immediate next step is to expand the study to include a larger and more diverse group of patients. This will help them validate their findings and identify any variations in the cell atlas based on factors like age, ethnicity, or stage of cancer. They likewise plan to delve deeper into the specific functions of the newly discovered perineural fibroblasts.

“We’ve had a peek through the window, but it’s still somewhat blurry,” says Professor Swarbrick. “Now we have more precise questions about these pre-malignant cells, and You can apply more focused techniques to be crystal clear about the sequence of genetic events that drive this cancer.” A key area of interest is understanding the role of cells that appear outwardly healthy but harbor subtle genetic changes that may predispose them to becoming cancerous. Identifying these “pre-malignant” cells could open up opportunities for early intervention and prevention.

The Role of Cancer-Associated Fibroblasts

Cancer-associated fibroblasts (CAFs) are a prominent component of the tumor microenvironment and play a complex role in cancer progression. They are not cancer cells themselves, but they actively support tumor growth by providing structural support, releasing growth factors, and suppressing the immune response. Research suggests CAFs can even induce neuroplasticity, altering the nervous system to favor tumor growth.

The discovery of perineural cancer-associated fibroblasts suggests that CAFs may be particularly important in mediating the interactions between tumors and the nervous system. Understanding how these specialized CAFs influence nerve growth and function could lead to new therapeutic targets.

From Fundamental Science to Clinical Application

The researchers are careful to emphasize that this work is still in its early stages and is not yet ready for clinical application. However, they believe that the findings have the potential to pave the way for future development of predictive tests that could identify patients at higher risk of aggressive disease. These tests could potentially be used to guide treatment decisions, ensuring that patients receive the most appropriate therapy based on the characteristics of their individual tumors.

Given the high incidence of prostate cancer – it’s the most common cancer in men – even small improvements in early detection and treatment selection could have a significant impact on public health. According to the American Cancer Society, about 1 in 8 men will be diagnosed with prostate cancer during their lifetime. This research, supported by philanthropic donations from Mr. John and Mrs. Deborah McMurtrie and The Petre Foundation, represents a crucial step forward in the ongoing effort to improve outcomes for men with this disease.

Looking Ahead: Refining Predictive Models

The research team is now focused on refining their understanding of the molecular mechanisms driving the interactions between perineural fibroblasts and nerves. This will involve further investigation of the signaling pathways involved and the identification of potential drug targets. The goal is to translate these fundamental discoveries into tangible benefits for patients, leading to earlier diagnosis, more effective treatments, and improved survival rates.